Additional information Details Original published date: Media and public enquiries Media Enquiries: Health Canada 613-957-2983 [email protected] Public Enquiries: 613-957-2991 1-866-225-0709 [email protected] Get notified Receive emails about new and updated recall and safety alerts.
A technical apparatus called an isolation Chip (iChip) made it possible to cultivate these bacteria and, thus, to isolate and discover a novel class antibiotic, teixobactin [70], which is now in the preclinical stage of development
This dose is typically given daily for the first week, followed by weekly injections for the first month, and then monthly maintenance doses
Strong preclinical evidence across 180+ PubMed papers (tendons, ligaments, gut mucosa, nerves, muscle)
Considering the size of the 81 analysed documents, i.e., each having between 100 and 500 pages of text, tables and visualizations, the procedure allows for a fast analysis of large amounts of data